India Botulinum Toxin Cdmo Market Size & Outlook, 2026-2033

The botulinum toxin cdmo market in India is expected to reach a projected revenue of US$ 225.9 million by 2033. A compound annual growth rate of 11% is expected of India botulinum toxin cdmo market from 2026 to 2033.
Revenue, 2025 (US$M)
$101.0
Forecast, 2033 (US$M)
$225.9
CAGR, 2026 - 2033
11%
Report Coverage
India

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

India botulinum toxin cdmo market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

India botulinum toxin cdmo market highlights

  • The India botulinum toxin cdmo market generated a revenue of USD 101.0 million in 2025 and is expected to reach USD 225.9 million by 2033.
  • The India market is expected to grow at a CAGR of 11% from 2026 to 2033.
  • In terms of segment, type a botulinum toxin was the largest revenue generating product in 2025.
  • Type B Botulinum Toxin is the most lucrative product segment registering the fastest growth during the forecast period.


Botulinum toxin cdmo market data book summary

Market revenue in 2025USD 101.0 million
Market revenue in 2033USD 225.9 million
Growth rate11% (CAGR from 2026 to 2033)
Largest segmentType a botulinum toxin
Fastest growing segmentType B Botulinum Toxin
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationType A Botulinum Toxin, Type B Botulinum Toxin


Other key industry trends

  • In terms of revenue, India accounted for 4.1% of the global botulinum toxin cdmo market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China botulinum toxin cdmo market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 399.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Botulinum Toxin CDMO Market Companies

Name Profile # Employees HQ Website
Hikal Ltd. View profile 1001-5000 Seattle, Washington, United States, North America https://www.hikal.com/
Apeloa Pharmaceutical View profile 5001-10000 Dongyang, Zhejiang, China, Asia http://www.apeloa.com
Cenexi View profile 1001-5000 Fontenay-sous-bois, Ile-de-France, France, Europe https://www.cenexi.com
Grand River Aseptic Manufacturing View profile 51-100 Grand Rapids, Michigan, United States, North America http://grandriverasepticmfg.com
Pharmaron View profile - - -
Cambrex Corporation View profile - - -
Recipharm AB View profile - - -
WuXi Biologics. View profile - - -
Vetter Pharma-Fertigung View profile 5001-10000 Ravensburg, Baden-Wurttemberg, Germany, Europe https://www.vetter-pharma.com/en
Samsung BioLogics View profile 1001-5000 Incheon, Inch'on-jikhalsi, South Korea, Asia https://www.samsungbiologics.com/
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
FUJIFILM Holdings Corp View profile 83784 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 http://www.fujifilmholdings.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com

India botulinum toxin cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin cdmo market will help companies and investors design strategic landscapes.


Type a botulinum toxin was the largest segment with a revenue share of 96.73% in 2025. Horizon Databook has segmented the India botulinum toxin cdmo market based on type a botulinum toxin, type b botulinum toxin covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to India botulinum toxin cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India botulinum toxin cdmo market databook

  • Our clientele includes a mix of botulinum toxin cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India botulinum toxin cdmo market , including forecasts for subscribers. This country databook contains high-level insights into India botulinum toxin cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India Product - Botulinum Toxin Cdmo Market size, 2025 - 2033 (US$M)

India Botulinum Toxin CDMO Market Outlook Share, 2025 & 2033 (US$M)

India Product - Botulinum Toxin Cdmo Market size, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online